跳至主要内容
临床试验/NCT00334971
NCT00334971Unknown不适用

Aromatase Activity and Ovarian Growth Factors in Preovulatory Follicles

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 116 人开始时间: 2004年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
116
试验地点
2
主要终点
RT-PCR results for aromatase in aspirated follicular fluid, when follicle is > 14 mm

研究概览

简要总结

The purpose of the study is to understand how the ovarian follicle (the fluid filled structure in the ovary that contains the egg) makes estrogen and other hormones during normal aging, in women with different ethnic backgrounds, and in Fragile X premutation carriers.

During reproductive aging, estradiol levels are increased, a phenomenon that may be related to increased aromatase activity. The investigators' own preliminary data suggest that estradiol is increased in African-American women compared to Caucasian women, which may also be related to aromatase activity. In addition, the investigators have examined female fragile X premutation carriers who still have regular menstrual cycles and have demonstrated evidence of early ovarian aging compared to age-matched controls.

**WE ARE RECRUITING ONLY WOMEN WITH FRAGILE-X PREMUTATION**

详细描述

The purpose of the study is to examine intrafollicular changes in aromatase and ovarian growth factors in reproductive aged women,African-American women compared to Caucasian controls, and Fragile X premutation carriers.

Hypotheses:

  • Aromatase activity is up-regulated in preovulatory follicles with aging, accounting for the increased estradiol levels in the face of decreased inhibin secretion in reproductive aging.
  • Increased estradiol in the face of normal inhibin A and inhibin B suggests up-regulation of aromatase in African-American women.
  • Aromatase activity is down-regulated in preovulatory follicles in fragile X premutation carriers compared to age-matched controls and the activity is associated with FMR1 mRNA levels.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Reproductively Younger Non-African-American Women:
  • 18-35 years of age
  • Body mass index (BMI) less than or equal to 30
  • Regular menstrual cycles (25-35 days long)
  • Negative beta-human chorionic gonadotrophin (HCG)
  • Normal prolactin and thyroid stimulating hormone (TSH) levels
  • Hemoglobin greater than or equal to 11.0 gm/dl
  • Luteal phase progesterone level indicating ovulation on a previous cycle (> 3 ng/ml)
  • Not currently trying to get pregnant
  • No blood donations within 2 months of initiating the blood sampling portion of the study
  • On no medications thought to interfere with normal menstrual cycle dynamics
  • Not current smokers or no exposure to passive smoke in the home or workplace (greater than 8 hours per day with a smoker of > 10 cigarettes per day)
  • Normal platelet count and PT/PTT
  • No history of pelvic adhesions and accessible ovarian position as assessed by transvaginal ultrasound
  • Reproductively Younger African-American Women:
  • 18-35 years of age
  • Meets all other inclusion criteria for the reproductively younger non-African-American population outlined above
  • Reproductively Older Non-African-American Women:
  • 36-45 years of age
  • Meets all other inclusion criteria for the reproductively younger non-African-American population outlined above.
  • Reproductive Aged Fragile X Premutation Carriers
  • Fragile X premutation carriers, with FMR1 CGG repeat lengths between 41 and
  • 18-45 years of age
  • Meets all other inclusion criteria for the reproductively younger non-African-American population outlined above.

排除标准

  • Hemoglobin level less than 11 gm/dl at time of screening

结局指标

主要结局

RT-PCR results for aromatase in aspirated follicular fluid, when follicle is > 14 mm

时间窗: after aspiration procedure

Serum androstenedione, E2, A/E2, inhibin A, and inhibin B

时间窗: at first day of menses until day after aspiration procedure

Follicular fluid androstenedione, E2, A/E2, inhibin A, and inhibin B

时间窗: after aspiration procedure

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Janet E. Hall, MD

Associate Physician

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验